Overview
FBRX market data
Price History
FBRX price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for FBRX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Forte Biosciences shares are trading higher after Barclays initiated coverage on the stock with an Overweight rating and announced a $74 price target.Benzinga · Jul 21, 2026, 2:40 PM
Barclays Initiates Coverage On Forte Biosciences with Overweight Rating, Announces Price Target of $74Benzinga · Jul 21, 2026, 12:45 PM
EquipmentShare, Vodafone, Circle Internet Group And Other Big Stocks Moving Higher On FridayBenzinga · Jul 10, 2026, 2:00 PM
Forte Biosciences Skin Pigmentation Disorder Drug Shows Strong Efficacy, Safety In Early StudyBenzinga · Jul 9, 2026, 4:30 PM
Gold Gains Over 1%; PepsiCo Shares Fall After Q2 ResultsBenzinga · Jul 9, 2026, 4:05 PM
Aehr Test Systems, Lam Research, Applied Materials And Other Big Stocks Moving Higher On ThursdayBenzinga · Jul 9, 2026, 2:05 PM
Forte Biosciences Reports Results From FB102 Double-Blind Placebo-Controlled Phase 1b Study In VitiligoBenzinga · Jul 9, 2026, 12:15 PM
8-K filing — Forte Biosciences, Inc. (FBRX)SEC EDGAR · Jul 9, 2026, 12:05 PM
Forte Biosciences Files $500M Shelf Registration For Potential Issuance Of Common Stock, Preferred Stock, Debt Securities, Warrants, And Other Securities From Time To TimeBenzinga · Jun 2, 2026, 8:49 PM
Forte Biosciences Q1 EPS $(1.24) Misses $(1.19) EstimateBenzinga · May 11, 2026, 1:06 PM